{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:30:48Z","timestamp":1786419048020,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-026-01050-8","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:25:05Z","timestamp":1780723505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["[18F] PSMA-3Q PET\/CT radiomics at 45% SUVmax threshold: predicting post-surgical ISUP grade\u2009\u2265\u20094 and extraprostatic extension for noninvasive stratification in prostate cancer management"],"prefix":"10.1186","volume":"26","author":[{"given":"Jianbo","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yachao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baixuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"3","key":"1050_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1050_CR2","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.juro.2010.10.057","volume":"185","author":"SE Eggener","year":"2011","unstructured":"Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol. 2011;185(3):869\u201375.","journal-title":"J Urol"},{"issue":"7","key":"1050_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.pathol.2017.08.008","volume":"49","author":"A Kristiansen","year":"2017","unstructured":"Kristiansen A, Drevin L, Delahunt B, Samaratunga H, Robinson D, Franck Lissbrant I, et al. Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study. Pathology. 2017;49(7):715\u201320.","journal-title":"Pathology"},{"issue":"2","key":"1050_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.eururo.2014.06.015","volume":"67","author":"BC Jeong","year":"2015","unstructured":"Jeong BC, Chalfin HJ, Lee SB, Feng Z, Epstein JI, Trock BJ, et al. The relationship between the extent of extraprostatic extension and survival following radical prostatectomy. Eur Urol. 2015;67(2):342\u20136.","journal-title":"Eur Urol"},{"issue":"4","key":"1050_CR5","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1007\/s00330-022-09240-1","volume":"33","author":"S Schir\u00f2","year":"2023","unstructured":"Schir\u00f2 S, Milanese G, Maddalo M, Ziglioli F, Maestroni UV, Manna C, et al. MR-based simplified extraprostatic extension evaluation: comparison of performances of different predictive models. Eur Radio. 2023;33(4):2975\u201384.","journal-title":"Eur Radio"},{"key":"1050_CR6","doi-asserted-by":"crossref","unstructured":"Hu JC, Assel M, Allaf ME, Ehdaie B, Vickers AJ, Cohen AJ, et al. Transperineal versus transrectal magnetic resonance imaging-targeted and systematic prostate biopsy to prevent infectious complications: the PREVENT randomized trial. European Urology. 2024 Jul;86(1):61-68.","DOI":"10.1016\/j.eururo.2023.12.015"},{"issue":"10071","key":"1050_CR7","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815\u201322.","journal-title":"Lancet"},{"issue":"4","key":"1050_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.eururo.2019.06.030","volume":"76","author":"A Paschalis","year":"2019","unstructured":"Paschalis A, Sheehan B, Riisnaes R, Rodrigues DN, Gurel B, Bertan C, et al. Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer. Eur Urol. 2019;76(4):469\u201378.","journal-title":"Eur Urol"},{"key":"1050_CR9","doi-asserted-by":"crossref","unstructured":"Y W, X Z, H Z, B X, J T, S S, et al. Synthesis, preclinical evaluation, and first-in-human study of Al18F-PSMA-Q for prostate cancer imaging. Eur J Nucl Med Mol Imaging. 2022 Jul;49(8).","DOI":"10.1007\/s00259-022-05775-z"},{"issue":"4","key":"1050_CR10","first-page":"201","volume":"43","author":"YC Liu","year":"2023","unstructured":"Liu YC, Zhang XJ, Liu J, Wang Y, Wang RM, Xu B, et al. Clinical value of F-PSMA-3Q PET\/CT in patients with low PSA levels after prostate cancer surgery. Chin J Nucl Med Mol Imaging. 2023;43(4):201\u20135.","journal-title":"Chin J Nucl Med Mol Imaging"},{"key":"1050_CR11","doi-asserted-by":"publisher","unstructured":"M PPLP. 68Ga-PSMA PET\/CT evaluation in men enrolled in prostate cancer active surveillance. Archivio Italiano di Urologia e Andrologia. 2023;95(2). https:\/\/doi.org\/10.4081\/aiua.2023.11322.","DOI":"10.4081\/aiua.2023.11322"},{"issue":"1154","key":"1050_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/bjr\/tqad038","volume":"97","author":"K Pan","year":"2024","unstructured":"Pan K, Yao F, Hong W, Xiao J, Bian S, Zhu D, et al. Multimodal radiomics based on 18F-Prostate-specific membrane antigen-1007 PET\/CT and multiparametric MRI for prostate cancer extracapsular extension prediction. Br J Radiol. 2024;97(1154):408\u201314.","journal-title":"Br J Radiol"},{"key":"1050_CR13","doi-asserted-by":"crossref","unstructured":"Bian L, Liu F, Peng Y, Liu X, Li P, Liu Q, et al. Using radiomics model for predicting extraprostatic extension with PSMA PET\/CT studies: a comparative study with the Mehralivand grading system. Cancer Imaging. 2025 Jun;18(1):77.","DOI":"10.1186\/s40644-025-00894-w"},{"issue":"2","key":"1050_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/cancers14020270","volume":"14","author":"PW Mihatsch","year":"2022","unstructured":"Mihatsch PW, Beissert M, Pomper MG, Bley TA, Seitz AK, K\u00fcbler H, et al. Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET\/CT. Cancers (Basel). 2022;14(2):270.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"1050_CR15","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1007\/s00261-024-04421-6","volume":"49","author":"S Bian","year":"2024","unstructured":"Bian S, Hong W, Su X, Yao F, Yuan Y, Zhang Y, et al. A dynamic online nomogram predicting prostate cancer short-term prognosis based on 18F-PSMA-1007 PET\/CT of periprostatic adipose tissue: a multicenter study. Abdom Radiol (NY). 2024;49(10):3747\u201357.","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"1050_CR16","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00261-024-04601-4","volume":"50","author":"F Yang","year":"2025","unstructured":"Yang F, Wang C, Shen J, Ren Y, Yu F, Luo W, et al. End-to-end [18F] PSMA-1007 PET\/CT radiomics-based pipeline for predicting ISUP grade group in prostate cancer. Abdom Radiol. 2025;50(4):1641\u201352.","journal-title":"Abdom Radiol"},{"key":"1050_CR17","doi-asserted-by":"crossref","unstructured":"Wu J, Xia Y, Wang X, Wei Y, Liu A, Innanje A, et al. uRP: An integrated research platform for one-stop analysis of medical images. Front Radiol. 2023;3.","DOI":"10.3389\/fradi.2023.1153784"},{"issue":"1","key":"1050_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s13139-019-00571-4","volume":"53","author":"S Ha","year":"2019","unstructured":"Ha S, Choi H, Paeng JC, Cheon GJ. Radiomics in oncological PET\/CT: a methodological overview. Nucl Med Mol Imaging. 2019;53(1):14\u201329.","journal-title":"Nucl Med Mol Imaging"},{"issue":"2","key":"1050_CR19","doi-asserted-by":"publisher","first-page":"e3286","DOI":"10.1002\/cnm.3286","volume":"36","author":"P Causin","year":"2020","unstructured":"Causin P, Lupieri MG, Naldi G, Weishaeupl RM. Mathematical and numerical challenges in optical screening of female breast. Int J Numer Methods Biomed Eng. 2020;36(2):e3286.","journal-title":"Int J Numer Methods Biomed Eng"},{"issue":"1","key":"1050_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13244-023-01572-w","volume":"15","author":"B Kocak","year":"2024","unstructured":"Kocak B, Akinci D\u2019Antonoli T, Mercaldo N, Alberich-Bayarri A, Baessler B, Ambrosini I, et al. METhodological RadiomICs score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII. Insights into Imaging. 2024;15(1):8.","journal-title":"Insights into Imaging"},{"issue":"11","key":"1050_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.6004\/jnccn.2025.0052","volume":"23","author":"DE Spratt","year":"2025","unstructured":"Spratt DE, Srinivas S, Adra N, Ahmed B, An Y, Bitting R, et al. Prostate cancer, version 3.2026, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw: JNCCN. 2025;23(11):469\u201393.","journal-title":"J Natl Compr Cancer Netw: JNCCN"},{"issue":"3","key":"1050_CR22","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","volume":"11","author":"LT Li","year":"2015","unstructured":"Li LT, Jiang G, Chen Q, Zheng JN. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep. 2015;11(3):1566\u201372.","journal-title":"Mol Med Rep"},{"issue":"5","key":"1050_CR23","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161(5):1215\u201328.","journal-title":"Cell"},{"key":"1050_CR24","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"4suppl","key":"1050_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1200\/JCO.2024.42.4_suppl.261","volume":"42","author":"JC Hu","year":"2024","unstructured":"Hu JC, Vickers A, Allaf ME, Ehdaie B, Cohen AJ, Ristau BT, et al. Randomized trial of transperineal versus transrectal prostate biopsy to prevent infection complications. JCO. 2024;42(4suppl):261\u2013261.","journal-title":"JCO"},{"key":"1050_CR26","doi-asserted-by":"publisher","unstructured":"P P, F F, A G, G G, S P, F A. Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed? Urology. 2008;72(6). https:\/\/doi.org\/10.1016\/j.urology.2008.05.045.","DOI":"10.1016\/j.urology.2008.05.045"},{"key":"1050_CR27","doi-asserted-by":"crossref","unstructured":"Stabile A, Giganti F, Rosenkrantz AB, Taneja SS, Villeirs G, Gill IS, et al. Multiparametric MRI for prostate cancer diagnosis: current status and future directions. Nat Rev Urol. 2020 Jan;17(1):41-61.","DOI":"10.1038\/s41585-019-0212-4"},{"issue":"1","key":"1050_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/MNM.0000000000000942","volume":"40","author":"E Demirci","year":"2019","unstructured":"Demirci E, Kabasakal L, Sahin OE, Akg\u00fcn E, G\u00fcltekin MH, Doganca T, et al. Can SUVmax values of Ga-68-PSMA PET\/CT scan predict the clinically significant prostate cancer? Nucl Med Commun. 2019;40(1):86.","journal-title":"Nucl Med Commun"},{"issue":"10","key":"1050_CR29","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1007\/s00330-024-10699-3","volume":"34","author":"G Marvaso","year":"2024","unstructured":"Marvaso G, Isaksson LJ, Zaffaroni M, Vincini MG, Summers PE, Pepa M, et al. Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models. Eur Radiol. 2024;34(10):6241\u201353.","journal-title":"Eur Radiol"},{"issue":"1","key":"1050_CR30","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1038\/s41598-025-86607-6","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, Chen M, Guo S, Xu Y, Liu L, Jiang X. Development and validation of biopsy free nomograms for predicting clinically significant prostate cancer in men with PI-RADS 4 and 5 lesions. Sci Rep. 2025;15(1):2506.","journal-title":"Sci Rep"},{"issue":"2","key":"1050_CR31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/JU.0000000000004025","volume":"212","author":"S Niu","year":"2024","unstructured":"Niu S, Ding X, Liu B, Ao L, Wang H, Chen W, et al. Radical Prostatectomy Without Prior Biopsy in Selected Patients Evaluated by 18F-Labeled Prostate-Specific Membrane Antigen-Ligand Positron Emission Tomography\/Computed Tomography and Multiparameter Magnetic Resonance Imaging: A Single-Center, Prospective, Single-Arm Trial. J Urol. 2024;212(2):280\u20139.","journal-title":"J Urol"},{"key":"1050_CR32","doi-asserted-by":"publisher","unstructured":"S V, P P, L P, N V, C A, A C, et al. BRCA mutations and prostate cancer: should urologist improve daily clinical practice? Archivio Italiano di Urologia e Andrologia. 2025;97(2). https:\/\/doi.org\/10.4081\/aiua.2025.13635.","DOI":"10.4081\/aiua.2025.13635"},{"issue":"2","key":"1050_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00259-020-04971-z","volume":"48","author":"MCF Cysouw","year":"2021","unstructured":"Cysouw MCF, Jansen BHE, van de Brug T, Oprea-Lager DE, Pfaehler E, de Vries BM, et al. Machine learning-based analysis of [18F] DCFPyL PET radiomics for risk stratification in primary prostate cancer. Eur J Nucl Med Mol Imaging. 2021;48(2):340\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"1050_CR34","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s11547-022-01541-1","volume":"127","author":"F Yao","year":"2022","unstructured":"Yao F, Bian S, Zhu D, Yuan Y, Pan K, Pan Z, et al. Machine learning-based radiomics for multiple primary prostate cancer biological characteristics prediction with [18F] PSMA-1007 PET: comparison among different volume segmentation thresholds. Radiol Med. 2022;127(10):1170\u20138.","journal-title":"Radiol Med"},{"issue":"10","key":"1050_CR35","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1007\/s00259-025-07248-5","volume":"52","author":"J Jiang","year":"2025","unstructured":"Jiang J, Fan Z, Jiang S, Chen X, Guo H, Dong S, et al. Interpretable multimodal deep learning model for predicting post-surgical international society of urological pathology grade in primary prostate cancer. Eur J Nucl Med Mol Imaging. 2025;52(10):3730\u201343.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1050_CR36","doi-asserted-by":"crossref","unstructured":"Guo F, Sun S, Deng X, Wang Y, Yao W, Yue P, et al. An interpretable clinical-radiomics-deep learning model based on magnetic resonance imaging for predicting postoperative Gleason grading in prostate cancer: a dual-center study. Front Oncol. 2025 Sep 18;15.","DOI":"10.3389\/fonc.2025.1615012"},{"key":"1050_CR37","doi-asserted-by":"crossref","unstructured":"Pan N, Shi L, He D, Zhao J, Xiong L, Ma L, et al. Prediction of prostate cancer aggressiveness using magnetic resonance imaging radiomics: a dual-center study. Discov Oncol. 2024 Apr;16:122.","DOI":"10.1007\/s12672-024-00980-8"},{"key":"1050_CR38","doi-asserted-by":"crossref","unstructured":"Gladis Pushparathi VP, Justin Xavier D, Chitra P, Kannan G. Prostate cancer classification and interpretation with multiparametric magnetic resonance imaging and Gleason grade score using DarkNet53 model. Prostate. 2025;85(3):294\u2013307.","DOI":"10.1002\/pros.24827"},{"issue":"8","key":"1050_CR39","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1158\/1078-0432.CCR-23-3052","volume":"30","author":"S Archer","year":"2024","unstructured":"Archer S, Brailey PM, Song M, Bartlett PD, Figureiredo I, Gurel B, et al. CB307: a dual targeting costimulatory humabody VH therapeutic for treating PSMA-positive tumors. Clin Cancer Res: Off J Am Assoc Cancer Res. 2024;30(8):1595\u2013606.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"1050_CR40","doi-asserted-by":"crossref","unstructured":"Qiu DX, Li J, Zhang JW, Chen MF, Gao XM, Tang YX, et al. Dual-tracer PET\/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study. Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2821\u20132832.","DOI":"10.1007\/s00259-021-05636-1"},{"issue":"10","key":"1050_CR41","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1007\/s00259-023-06492-x","volume":"51","author":"H Fu","year":"2024","unstructured":"Fu H, Lou K, He H, Wang Y, Mi Y, Li W, et al. A novel PSMA targeted dual-function near-infrared fluorescence and PET probe for the image-guided surgery and detection of prostate cancer. Eur J Nucl Med Mol Imaging. 2024;51(10):2998\u20133008.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1050_CR42","first-page":"21","volume":"11","author":"DC Feng","year":"2024","unstructured":"Feng DC, Zhu WZ, Wang J, Li DX, Shi X, Xiong Q, et al. The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy. Mil Med Res. 2024;11(1):21.","journal-title":"Mil Med Res"},{"issue":"1","key":"1050_CR43","doi-asserted-by":"publisher","first-page":"12132","DOI":"10.4081\/aiua.2024.12132","volume":"96","author":"P Pepe","year":"2024","unstructured":"Pepe P, Pepe L, Curduman M, Pennisi M, Fraggetta F. Ductal prostate cancer staging: role of PSMA PET\/CT. Arch Ital Urol Androl: Organo Uff [di] Soc Ital Ecogr Urol Nefrol. 2024;96(1):12132. https:\/\/doi.org\/10.4081\/aiua.2024.12132.","journal-title":"Arch Ital Urol Androl: Organo Uff [di] Soc Ital Ecogr Urol Nefrol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01050-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01050-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01050-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:07:20Z","timestamp":1786417640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-026-01050-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-01050-8","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Medical Ethics Committee of the Chinese People\u2019s Liberation Army General Hospital (Approval Number: S2026-109-01).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"103"}}